Navigation Links
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:5/19/2010

CAMBRIDGE, Mass., May 19 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the 2010 Citi Annual Global Health Care Conference on Wednesday, May 26, 2010 at 2:00 p.m. ET at the Hilton hotel, New York City and at the Jefferies 2010 Global Life Sciences Conference on June 10, 2010 at 4:00 p.m. ET at the Grand Hyatt hotel, New York City.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com.  Please log in approximately 5-10 minutes before the event to ensure a timely connection.  The archived replay will be available on the Idenix website for two weeks following the conference.  

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV
2. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
3. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
6. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
7. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
8. Idenix Pharmaceuticals Reports First Quarter Financial Results
9. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
10. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
11. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... water with ultrasound and they,ll spin around their long ... knows exactly. But researchers at the National Institute of ... fast. At up to 150,000 revolutions per minute, these ... submerged in liquid ever reported. , The discovery of ... they could be used not only for moving around ...
(Date:7/22/2014)... 2014   BioTE Medical , a leading ... hormone pellets, today announced the addition of Dr. ... Dr. Rouzier is joining the BioTE Medical Advisory ... Dr. Rouzier was residency trained in Family Medicine ... board certified emergency physician still practicing at a ...
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer ... cosmetics, and other markets, announced today that it has ... qualified private investors led by Novit L.P., an investment ... transaction involved the signing of a Securities Purchase Agreement ... Stock at a price per share of $1.00, resulting ...
(Date:7/22/2014)... Rice Lake, Wisconsin (PRWEB) July 22, 2014 ... will be in attendance at the 2014 NCSL ... Florida. Booth #423 will feature CONDEC pressure ... balance style weights, and the new, customized sets, ... years ago to promote cooperative efforts in solving ...
Breaking Biology Technology:NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2
... Company Posts Record Quarterly EPS of $0.58, 45% Above Prior Year, Based ... - Total Revenues Increase 21% to Establish Quarterly Record of $122.6 Million, ... 2008, Company Now Expects EPS of $1.72 to $1.76, Total Revenues of ... $450 to $455 Million -, ...
... commercial launch of first ... ... medicine,company, announced that Al Lucas has joined the Company as vice ... marketing,plan and initial launch strategy, building the sales force, and leading ...
... ,Monsanto Company (NYSE: MON ) and Mendel ... the development of Mendel,s BioEnergy,Seeds & Feedstocks business. ... from Monsanto,s industry-leading expertise in the testing,breeding, and ... worked together on the development of,biotechnology traits for ...
Cached Biology Technology:Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 2Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 3Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 4Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 5Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 6Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 7Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 8Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 9Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 10Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 11Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 12Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance 13AssureRx Adds VP of Sales and Marketing 2Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration 2
(Date:7/22/2014)... most kids will hear that drinking milk helps make their bones ... these messages foster the idea that if something is good for ... in the Journal of Consumer Research , when children hear ... it. , "We predicted that when food is presented to children ... goal such as learning how to read or count, they would ...
(Date:7/22/2014)... July 22, 2014 BGI Tech Solutions ... the world,s largest genomics organization, announced today the ... sequencing service based on Complete Genomics, industry-leading platform. ... and SNP validation, and is available at reduced ... Genomics, highly regarded in the industry for providing ...
(Date:7/22/2014)... Nancy Buccola, MSN, APRN, PMHCNS-BC, CNE, Assistant Professor ... New Orleans School of Nursing, contributed samples used ... material associated with schizophrenia and also suggesting a ... The study, Biological insights from 108 schizophrenia-associated genetic ... Nature , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2
... appears to increase a person,s risk of developing late-onset Alzheimer,s ... will be presented as part of the late-breaking science program ... Toronto, April 10 17, 2010. The gene, abbreviated MTHFD1L, ... common variants in genes other than APOE been convincingly shown ...
... COLUMBUS, Ohio Scientists here are taking the trial and ... identify molecular structures that have the highest potential to serve ... designed to act on proteins that somehow malfunction in ways ... active ingredient in these medicines is typically a single molecule ...
... in French . , A new study, the ... techniques, to provide a more comprehensive and accurate picture of ... the April issue of neuroimaging journal Human Brain Mapping, ... and Hospital The Neuro, McGill University and the Universit ...
Cached Biology News:New gene associated with increased risk of Alzheimer's disease 2New drug design technique could dramatically speed discovery process 2New drug design technique could dramatically speed discovery process 3Dual approach gives a more accurate picture of the autistic brain 2Dual approach gives a more accurate picture of the autistic brain 3
1M stock solution (238mg/ml)...
...
Request Info...
... peptide derived from the C-terminal region catalytic ... C zeta isoform (PKCzeta). Specificity: Reacts ... Recognizes PKCzeta and PKMzeta (PKCzeta II) ... Reactivity: Mouse Rat (positive controls: mouse and ...
Biology Products: